Small bowel adenocarcinoma

The names of the lead clinicians for the IRCI Small bowel adenocarcinoma group include:

Dr Rob McWilliams (US)
Dr Arnaud Roth (EORTC)
Dr Richard Wilson (UK)

Current active trial

Current active trial: BALLAD – A global study to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (International Rare Cancers Initiative study – IRCI 002)

› Read more

Informative websites

Cancer Help, Cancer Research UK

National Cancer Institute

Institut National Du Cancer

Rare Cancer Types

Active groups

Closed groups